Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1988-04-15
1990-09-11
Lipovsky, Joseph A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514 99, 514102, 514121, 514172, 514171, A61K 3156, A61K 3158, A61K 31665, A61K 3166
Patent
active
049563556
ABSTRACT:
Compounds of the general Formula (I) ##STR1## in which R is a hydrogen atom or a bromine atom, and R.sub.1 is a hydrogen atom, an SO.sub.2 OM group wherein M is a hydrogen or sodium atom, various sulphatide or phosphatide groups or a glucuronide group are disclosed for use in the prophylaxis and therapy of retroviral infections, especially infection by Human Immunodeficiency Virus. These compounds may be used concomitantly or in combination with various immunomodulators and/or antiviral agents.
REFERENCES:
patent: 4005200 (1977-01-01), Utsumi et al.
patent: 4518595 (1985-05-01), Coleman et al.
patent: 4602008 (1986-07-01), Krsek
patent: 4628052 (1986-12-01), Peat
patent: 4724232 (1988-02-01), Rideout et al.
The Merck Index, 10th ed. (1983); p. 1108; #7606 Prasterone.
Chemical Abstracts; vol. 100 (1984) #168,451e; Schwartz et al.
Crowe, et al., Quantitative Immunocytofluorographic Analysis . . . AIDS Research & Human Retroviruses, vol. 3, No. 2, 1987, pp. 135-145.
Henderson, et al., Dehydroepiandrosterone and 16.alpha.-bromo-epiandrosterone: Inhibitors of Epstein-Barr Virus-Induced Transformation of Human Lymphocytes, Carcinogenesis, vol. 2, No. 7, 1981, pp. 683-686.
Hidvegi, et al., Inhibition of the Complement Activation by an Adrenal Androgen, Dehydroepiandrosterone, Complement 1:201-206 (1984).
Ho, et al., Infection of Monocyte/Macrophages by Human T Lymphotropic Virus Type III, The American Society for Clinical Investigation, Inc., vol. 77, May 86, pp. 1712-1715.
Koo, et al., Effect of Dehydroepiandrosterone on Hereditary Angiodema, Klin Wochenschr, (1983) 61:715-717.
Lucas, et al., Prevention of Autoantibody Formation & Prolonged Survival in New Zealand . . . , The American Society of Clinical Investigations, Inc., vol. 75, Jun. 85, 2091-2093.
Church Marla J.
Colthurst Limited
Lipovsky Joseph A.
LandOfFree
Agents for the arrest and therapy of retroviral infections does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Agents for the arrest and therapy of retroviral infections, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agents for the arrest and therapy of retroviral infections will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1184935